‘Vaginal atrophy’ no longer PC

An international consensus is that from now on ‘genitourinary syndrome of menopause’, or GSM, will be used to refer to symptoms and signs associated with a decrease in oestrogen and other hormones involving changes to the vulva, vagina, clitoris, introitus, urethra and bladder.

Writing in the Journal of Sexual Medicine, the specialists who made the decision hope that ‘GSM’ catches on with the public, saying that “the word ‘vagina’ is not a generally accepted term for public discourse or for the media”.

The new term was coined last year by delegates to a special meeting co-sponsored by the International Society for the Study of Women’s Sexual Health and the North American Menopause Society and funded by grants from corporations including Bayer, NovoNordisk and Warner Chilcott.

The women’s health specialists said there were good clinical reasons for making the change, as vulvovaginal atrophy